Skip to content

Nutrition Beverage Tolerance Study

Nutrition Beverage Tolerance Study

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01464385
Enrollment
121
Registered
2011-11-03
Start date
2011-10-31
Completion date
2011-12-31
Last updated
2012-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Volunteers

Brief summary

To evaluate the sensations experienced by subjects consuming a nutritional beverage.

Interventions

Nutritional Beverage Oral 237mL

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Subject ≥ 45 years of age. If female, subject is either postmenopausal for at least 1 year or surgically sterile Subject reports that he/she has not participated in a research study in the last three months.

Exclusion criteria

Subject has active metabolic or endocrine disease Subject has an autoimmune disorder Subject has a disorder of gastrointestinal tract or any gastrointestinal surgery in past 12 months. Subject has food allergy, celiac disease or intolerance to any of the ingredients in the study products Subject reports history of parasthesia; and/or is currently taking medication/dietary supplements/substances that may cause parasthesia for 4 weeks prior to screening

Design outcomes

Primary

MeasureTime frame
Proportion of subjects experiencing neurologic adverse event(s)2-3 weeks

Secondary

MeasureTime frame
Proportion of subjects experiencing any adverse event(s).2-3 Weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026